Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Clin Transl Med. 2021 Mar;11(3):e350. doi: 10.1002/ctm2.350.
Lung adenocarcinoma (LUAD) patients with different American Joint Committee on Cancer stages have different overall 5-year survival rates. The tumor microenvironment (TME) and intra-tumor heterogeneity (ITH) have been shown to play a crucial role in the occurrence and development of tumors. However, the TME and ITH in different lesions of LUAD have not been extensively explored.
We present a 204,157-cell catalog of the TME transcriptome in 29 lung samples to systematically explore the TME and ITH in the different stages of LUAD. Traditional RNA sequencing data and complete clinical information were downloaded from publicly available databases.
Based on these high-quality cells, we constructed a single-cell network underlying cellular and molecular features of normal lung, early LUAD, and advanced LUAD cells. In contrast with early malignant cells, we noticed that advanced malignant cells had a remarkably more complex TME and higher ITH level. We also found that compared with other immune cells, more differences in CD8+/CTL T cells, regulatory T cells, and follicular B cells were evident between early and advanced LUAD. Additionally, cell-cell communication analyses, revealed great diversity between different lesions of LUAD at the single-cell level. Flow cytometry and qRT-PCR were used to validate our results.
Our results revealed the cellular diversity and molecular complexity of cell lineages in different stages of LUAD. We believe our research, which serves as a basic framework and valuable resource, can facilitate exploration of the pathogenesis of LUAD and identify novel therapeutic targets in the future.
不同美国癌症联合委员会(AJCC)分期的肺腺癌(LUAD)患者的总 5 年生存率不同。肿瘤微环境(TME)和肿瘤内异质性(ITH)已被证明在肿瘤的发生和发展中起关键作用。然而,LUAD 不同病变部位的 TME 和 ITH 尚未得到广泛探讨。
我们展示了 29 个肺样本中 204157 个 TME 转录组细胞的目录,以系统地探索 LUAD 不同分期的 TME 和 ITH。从公共数据库下载了传统的 RNA 测序数据和完整的临床信息。
基于这些高质量的细胞,我们构建了一个单细胞网络,揭示了正常肺、早期 LUAD 和晚期 LUAD 细胞的细胞和分子特征。与早期恶性细胞不同,我们注意到晚期恶性细胞的 TME 更为复杂,ITH 水平更高。我们还发现,与其他免疫细胞相比,早期和晚期 LUAD 之间 CD8+/CTL T 细胞、调节性 T 细胞和滤泡 B 细胞的差异更为明显。此外,细胞间通讯分析揭示了不同 LUAD 病变在单细胞水平上的巨大差异。通过流式细胞术和 qRT-PCR 验证了我们的结果。
我们的结果揭示了 LUAD 不同分期中细胞谱系的细胞多样性和分子复杂性。我们相信,我们的研究为探索 LUAD 的发病机制和未来确定新的治疗靶点提供了一个基本框架和有价值的资源。